Financials
Financial year 2025
MDB PHARMA from Gent, company number BE0767385410, closed financial year 2025 with a result of € 59,366 after tax. For that financial year MDB PHARMA recorded a gross margin of € 78,348 and equity of € 190,172. Compared with financial year 2024, the result moved from € 39,097 to € 59,366. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 190,172
▲ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 59,366
▲ 52% vs 2024
Profit after tax over the fiscal year.
€ 151,951
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 187,172.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 5,970
▲ 66% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,194
▼ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 15,306
▲ 11% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 63,414 | € 75,211 | € 54,255 | € 78,348 | ▲ 44% |
| Profit after taxes | € 38,227 | € 52,174 | € 39,097 | € 59,366 | ▲ 52% |
| Equity | € 41,227 | € 92,568 | € 130,806 | € 190,172 | ▲ 45% |
| Total debts | € 37,416 | € 26,191 | € 26,316 | € 24,639 | ▼ 6% |
| Cash | € 37,037 | € 96,883 | € 136,321 | € 151,951 | ▲ 11% |
| Retained profit | € 38,227 | € 89,568 | € 127,806 | € 187,172 | ▲ 46% |
| Dividend | € 0 | € 833 | € 859 | € 0 | ▼ 100% |
| Balance sheet total | € 78,643 | € 118,759 | € 157,121 | € 214,811 | ▲ 37% |
Key figures of MDB PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MDB PHARMA?
What happened at MDB PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 59,366 (▲ 52% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Gent. KBO
- Marie De Backer became a director. NBB
In short
From € 38,227 profit in 2022 to € 59,366 profit in 2025.
Paid € 54,590 in corporate taxes since 2022.
Best year ever: 2025, with € 59,366 profit.
Paid out € 1,692 in dividends to the owners in total.
Management
Behind MDB PHARMA is Marie De Backer.
Directors
According to the 2025 annual accounts
Marie De Backer
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Iepenstraat 70
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DE BACKER Marie Rosette Gilbert(oprichter) 100%
Details
- Company number
- 0767.385.410
- VAT number
- BE 0767.385.410
- Registered office
- Iepenstraat 70, 9000 Gent
- Names & denominations
- MDB PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 April 2021
- Peppol
- Active · Active since 31 Oct 2023
- Activities · NACE
Detailhandel in farmaceutische producten